Research.Patient.info
Hypereosinophilic Syndrome research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE3
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
This study looks at a new drug called benralizumab for Hypereosinophilic Syndrome (HES) in people aged 12 and over. It compares benralizumab to a dummy drug to see if it's safe and helps reduce HES symptoms.
United States · Argentina · Austria - recruitingPHASE3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
This 52-week study is testing a new drug, depemokimab, for adults with uncontrolled Hypereosinophilic Syndrome (HES). It aims to see if depemokimab is effective and safe compared to a placebo, alongside their usual HES treatment.
United States · Argentina · Australia - ongoing, recruitingTherapeutic confirmatory (Phase III)
Expanded access program for mepolizumab in subjects with hypereosinophilic syndrome.
This study is for adults with a rare blood condition called Hypereosinophilic Syndrome (HES). It's looking at a medicine called mepolizumab to see if it's a safe and helpful treatment. This is an advanced-stage trial, confirming how well the treatment works.
Poland